These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

407 related items for PubMed ID: 27393712

  • 21. The L-arginine/NO pathway, homoarginine, and nitrite-dependent renal carbonic anhydrase activity in young people with type 1 diabetes mellitus.
    Carmann C, Lilienthal E, Weigt-Usinger K, Schmidt-Choudhury A, Hörster I, Kayacelebi AA, Beckmann B, Chobanyan-Jürgens K, Tsikas D, Lücke T.
    Amino Acids; 2015 Sep; 47(9):1865-74. PubMed ID: 26123986
    [Abstract] [Full Text] [Related]

  • 22. Role of MicroRNAs in Type 2 Diabetes and Associated Vascular Complications.
    Banerjee J, Nema V, Dhas Y, Mishra N.
    Biochimie; 2017 Aug; 139():9-19. PubMed ID: 28487136
    [Abstract] [Full Text] [Related]

  • 23. Age-related changes in ADMA-DDAH-NO pathway in rat liver subjected to partial ischemia followed by global reperfusion.
    Trocha M, Merwid-Ląd A, Chlebda-Sieragowska E, Szuba A, Pieśniewska M, Fereniec-Gołębiewska L, Kwiatkowska J, Szeląg A, Sozański T.
    Exp Gerontol; 2014 Feb; 50():45-51. PubMed ID: 24269305
    [Abstract] [Full Text] [Related]

  • 24. ADMA, SDMA and L-arginine/ADMA ratio but not DDAH genetic polymorphisms are reliable predictors of diabetic nephropathy progression as identified by competing risk analysis.
    Tanhäuserová V, Tomandl J, Pácal L, Klepárník M, Malúšková D, Bartáková V, Kuricová K, Rehořová J, Stěpánková S, Svojanovský J, Olšovský J, Bělobrádková J, Krusová D, Jurajda M, Mužík J, Pavlík T, Kaňková K.
    Kidney Blood Press Res; 2012 Feb; 36(1):200-8. PubMed ID: 23147199
    [Abstract] [Full Text] [Related]

  • 25. Uncomplicated type 1 diabetes is associated with increased asymmetric dimethylarginine concentrations.
    Altinova AE, Arslan M, Sepici-Dincel A, Akturk M, Altan N, Toruner FB.
    J Clin Endocrinol Metab; 2007 May; 92(5):1881-5. PubMed ID: 17311854
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Asymmetric dimethylarginine, cortisol/cortisone ratio, and C-peptide: markers for diabetes and cardiovascular risk?
    Anderson JL, Carlquist JF, Roberts WL, Horne BD, May HT, Schwarz EL, Pasquali M, Nielson R, Kushnir MM, Rockwood AL, Bair TL, Muhlestein JB, Intermountain Heart Collaborative Study Group.
    Am Heart J; 2007 Jan; 153(1):67-73. PubMed ID: 17174641
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease: results from the AtheroGene Study.
    Schnabel R, Blankenberg S, Lubos E, Lackner KJ, Rupprecht HJ, Espinola-Klein C, Jachmann N, Post F, Peetz D, Bickel C, Cambien F, Tiret L, Münzel T.
    Circ Res; 2005 Sep 02; 97(5):e53-9. PubMed ID: 16100045
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Relation of asymmetric dimethylarginine levels to macrovascular disease and inflammation markers in type 2 diabetic patients.
    Celik M, Cerrah S, Arabul M, Akalin A.
    J Diabetes Res; 2014 Sep 02; 2014():139215. PubMed ID: 24804267
    [Abstract] [Full Text] [Related]

  • 32. Asymmetric dimethylarginine and carotid atherosclerosis in Type 2 diabetes mellitus.
    Xia W, Shao Y, Wang Y, Wang X, Chi Y.
    J Endocrinol Invest; 2012 Oct 02; 35(9):824-7. PubMed ID: 23135319
    [Abstract] [Full Text] [Related]

  • 33. Arginine/asymmetric dimethylarginine ratio and cardiovascular risk factors in patients with predialytic chronic kidney disease.
    Hov GG, Sagen E, Hatlen G, Bigonah A, Åsberg A, Aasarød K.
    Clin Biochem; 2011 Jun 02; 44(8-9):642-6. PubMed ID: 21406191
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA), arginine, and 8-iso-prostaglandin F2alpha (8-iso-PGF2alpha) level in patients with inflammatory bowel diseases.
    Owczarek D, Cibor D, Mach T.
    Inflamm Bowel Dis; 2010 Jan 02; 16(1):52-7. PubMed ID: 19575355
    [Abstract] [Full Text] [Related]

  • 37. [Asymmetric dimethylarginine (ADMA) in children with diabetes type 1].
    Głowińska-Olszewska B, Luczyński W, Jabłońska J, Otocka A, Florys B, Bossowski A.
    Pediatr Endocrinol Diabetes Metab; 2010 Jan 02; 16(3):137-41. PubMed ID: 21092689
    [Abstract] [Full Text] [Related]

  • 38. The effects of thyroxine replacement on the levels of serum asymmetric dimethylarginine (ADMA) and other biochemical cardiovascular risk markers in patients with subclinical hypothyroidism.
    Ozcan O, Cakir E, Yaman H, Akgul EO, Erturk K, Beyhan Z, Bilgi C, Erbil MK.
    Clin Endocrinol (Oxf); 2005 Aug 02; 63(2):203-6. PubMed ID: 16060915
    [Abstract] [Full Text] [Related]

  • 39. Regular physical exercise normalizes elevated asymmetrical dimethylarginine concentrations in patients with type 1 diabetes mellitus.
    Mittermayer F, Pleiner J, Krzyzanowska K, Wiesinger GF, Francesconi M, Wolzt M.
    Wien Klin Wochenschr; 2005 Dec 02; 117(23-24):816-20. PubMed ID: 16437318
    [Abstract] [Full Text] [Related]

  • 40. Asymmetric dimethylarginine as a risk marker for early-onset ischemic stroke in Indian population.
    Mamatha SN, Nagaraja D, Philip M, Christopher R.
    Clin Chim Acta; 2011 Jan 14; 412(1-2):139-42. PubMed ID: 20883678
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.